Stock Events

Stock Events

Aptamer Group 

GBX0.6
6
+GBX0.03+4.35% Today

Statistics

Day High
0.6
Day Low
0.59
52W High
1.3
52W Low
0.29
Volume
2,904,507
Avg. Volume
-
Mkt Cap
11.95M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25MarExpected
Q4 2021
Q3 2022
Q4 2023
Q3 2024
Q4 2024
Q3 2025
Q4 2025
-0.02
0.15
0.33
0.5
Expected EPS
N/A
Actual EPS
N/A

Financials

-201.5%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
240.6MRevenue
-484.8MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow APTA.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap40.77B
Alnylam Pharmaceuticals focuses on RNAi therapeutics, closely related to aptamer technology used by Aptamer Group.
Ionis Pharmaceuticals
IONS
Mkt Cap12.1B
Ionis Pharmaceuticals specializes in antisense technology, which is similar to aptamer-based methods in targeting genetic disorders.
Arrowhead Pharmaceuticals
ARWR
Mkt Cap10.35B
Arrowhead Pharmaceuticals is involved in developing RNAi therapeutics, a field closely related to aptamers.
Sarepta Therapeutics
SRPT
Mkt Cap2.13B
Sarepta Therapeutics engages in the development of RNA-based therapeutics, competing in the same broader biotech space as Aptamer.
CRISPR Therapeutics
CRSP
Mkt Cap4.7B
CRISPR Therapeutics is known for gene editing, a cutting-edge technology that competes with aptamer technology in genetic medicine.
Editas Medicine
EDIT
Mkt Cap284.81M
Editas Medicine specializes in CRISPR gene editing, competing in the genomic medicine field alongside aptamer technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.61B
Intellia Therapeutics is another key player in CRISPR technology, directly competing with companies developing alternative genetic therapies like aptamers.

About

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and bioprocessing companies. It has collaborations with Unilever, Neuro-Bio, the University of Glasgow, AstraZeneca, and Invizius. Aptamer Group PLC was founded in 2008 and is headquartered in York, the United Kingdom.
Show more...
CEO
Dr. Arron Craig Tolley
Employees
30
Country
United Kingdom
ISIN
GB00BNRRP542

Listings

STU
DE
P0J.STU
LSE
GB
APTA.LSE
F
DE
P0J.F

0 Comments

Share your thoughts

FAQ

What is Aptamer Group stock price today?▼
The current price of APTA.LSE is GBX0.6 GBX — it has increased by +4.35% in the past 24 hours. Watch Aptamer Group stock price performance more closely on the chart.
What is Aptamer Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aptamer Group stocks are traded under the ticker APTA.LSE.
Is Aptamer Group stock price growing?▼
APTA.LSE stock has fallen by -7.98% compared to the previous week, the month change is a +0% rise, over the last year Aptamer Group has showed a +84.62% increase.
What is Aptamer Group market cap?▼
Today Aptamer Group has the market capitalization of 11.95M
When is the next Aptamer Group earnings date?▼
Aptamer Group is going to release the next earnings report on October 20, 2026.
What is Aptamer Group revenue for the last year?▼
Aptamer Group revenue for the last year amounts to 240.6M GBX.
What is Aptamer Group net income for the last year?▼
APTA.LSE net income for the last year is -484.8M GBX.
How many employees does Aptamer Group have?▼
As of April 29, 2026, the company has 30 employees.
In which sector is Aptamer Group located?▼
Aptamer Group operates in the Health & Wellness sector.
When did Aptamer Group complete a stock split?▼
Aptamer Group has not had any recent stock splits.
Where is Aptamer Group headquartered?▼
Aptamer Group is headquartered in York, United Kingdom.